Cargando…
Impact of National Centralized Drug Procurement Policy on Antiviral Utilization and Expenditure for Hepatitis B in China
BACKGROUND AND AIMS: The National Centralized Drug Procurement (NCDP) policy was launched in mainland China in April 2019, with entecavir (ETV) and tenofovir disoproxil fumarate (TDF) being included in the procurement list. We conducted the current study to investigate the impact of the NCDP policy...
Autores principales: | Zhao, Xinyu, Li, Min, Wang, Hao, Xu, Xiaoqian, Wu, Xiaoning, Sun, Yameng, Ning, Canjian, Wang, Bingqiong, Chen, Shuyan, You, Hong, Jia, Jidong, Kong, Yuanyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240235/ https://www.ncbi.nlm.nih.gov/pubmed/35836769 http://dx.doi.org/10.14218/JCTH.2022.00167 |
Ejemplares similares
-
Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients
por: Wu, Xiaoning, et al.
Publicado: (2023) -
The Impacts of National Centralized Drug Procurement Policy on Drug Utilization and Drug Expenditures: The Case of Shenzhen, China
por: Chen, Lei, et al.
Publicado: (2020) -
SHG/TPEF-based image technology improves liver fibrosis assessment of minimally sized needle biopsies
por: Wang, Bingqiong, et al.
Publicado: (2019) -
CERN Procurement Strategy and Policy
Publicado: (2011) -
Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study
por: Wu, Xiaoning, et al.
Publicado: (2019)